Valuation: Epigral Limited

Market Cap 48.6B 510M 441M 412M 377M 710M 721M 4.84B 1.9B 24.31B 1.91B 1.87B 80.98B P/E 2027 *
14x
P/E 2028 * 11.1x
Enterprise Value 54.52B 572M 495M 463M 423M 797M 809M 5.42B 2.13B 27.27B 2.15B 2.1B 90.84B EV / Sales 2027 *
1.77x
EV / Sales 2028 * 1.45x
Free-Float
31.14%
Yield 2027 *
0.49%
Yield 2028 * 0.49%
1 day+2.32%
1 week+0.80%
Current month+3.41%
1 month+15.14%
3 months-15.09%
6 months+8.36%
Current year-7.55%
1 week 1,090.05
Extreme 1090.05
1,138.5
1 month 970.15
Extreme 970.15
1,214.35
Current year 806.2
Extreme 806.2
1,401.35
1 year 806.2
Extreme 806.2
1,944.75
3 years 806.2
Extreme 806.2
2,408.35
5 years 386.35
Extreme 386.35
2,408.35
10 years 386.35
Extreme 386.35
2,408.35
Manager TitleAgeSince
Chief Executive Officer 41 -
Director of Finance/CFO - 2025-11-09
Compliance Officer - 2024-04-21
Director TitleAgeSince
Director/Board Member 75 2017-05-17
Director/Board Member 43 2016-10-04
Director/Board Member 41 2017-05-17
Change 5-day change 1-year change 3-year change Capi.($)
-0.73%+0.80% - - 510M
-0.55%+0.66%+8.52%+27.16% 126B
-1.60%+12.12%+402.72%+165.42% 45.47B
-0.29%+0.10%-11.07%-41.58% 40.75B
+3.02%+3.60%+28.31%-19.37% 36.2B
+0.97%+4.32%+54.29%+70.35% 25.76B
-0.89%+11.60%+76.35%+267.84% 20.74B
-0.37%+16.18%+358.59%+599.72% 19.28B
+5.14%+3.35%+27.70%-37.79% 20.24B
+2.19%+10.28%+47.92%+6.29% 19.18B
Average +0.99%+5.91%+110.37%+115.34% 39.29B
Weighted average by Cap. +0.29%+3.78%+88.60%+75.87%

Financials

2027 *2028 *
Net sales 30.88B 324M 280M 262M 239M 451M 458M 3.07B 1.21B 15.45B 1.22B 1.19B 51.44B 37.28B 391M 338M 316M 289M 545M 553M 3.71B 1.46B 18.65B 1.47B 1.44B 62.11B
Net income 3.47B 36.34M 31.46M 29.4M 26.87M 50.64M 51.43M 345M 135M 1.73B 136M 133M 5.77B 4.4B 46.1M 39.91M 37.31M 34.09M 64.25M 65.25M 437M 172M 2.2B 173M 169M 7.33B
Net Debt 5.92B 62.03M 53.7M 50.2M 45.88M 86.45M 87.8M 589M 231M 2.96B 233M 228M 9.86B 5.49B 57.55M 49.82M 46.57M 42.56M 80.2M 81.45M 546M 214M 2.75B 216M 211M 9.14B
Logo Epigral Limited
Epigral Limited is an India-based manufacturer of essential chemicals. The Company is engaged in the manufacturing and selling of chemicals, including derivatives and specialty chemicals. It operates under two businesses, Chlor-Alkali and Derivatives and Speciality chemicals, which relate to the manufacturing of Chlor-Alkali & its Derivatives. Chlor-Alkali is an industrial process that offers Sodium Hypochlorite, Hydrogen Gas, Caustic Soda Lye, Caustic Soda Flakes, and Liquid Chlorine. The Company offers a diverse portfolio of products, including chlorinated polyvinyl chloride (CPVC) Resin, CPVC Compound, Chlorotoluenes Value Chain, Epichlorohydrin, Chloromethanes, Hydrogen Peroxide, Caustic Soda, Chlorine, Hydrogen, and Caustic Potash. The Company caters to a range of industries such as refineries, paper and pulp, fluoropolymers, soaps & detergents, textiles, dyes & pigment, pharmaceuticals, agrochemicals, paints and coating, refrigerant gas, electronics, water treatment, and others.
Employees
1,135
Date Price Change Volume
26-08-11 1,119.00 -0.73% 917
26-08-10 ₹1,127.25 +2.32% 5,113
26-08-07 ₹1,101.70 +0.41% 1,595
26-08-06 ₹1,097.15 -1.81% 2,407
26-08-05 ₹1,117.35 +1.31% 3,210
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1,126.60INR
Average target price
1,728.00INR
Spread / Average Target
+53.38%

Quarterly revenue - Rate of surprise